3 Dividend Growers Suited for Income Investors
It's easy to understand why dividends are so cherished among investors, as they provide a passive income stream, help limit the impact of drawdowns in other positions, and allow for maximum returns...
Wearable Technology Market Gains Ground, 3 Stocks in Focus
In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.
7 Upcoming Dividend Increases, Including The 'Abbott's' And A Dividend King
Seven stocks are expected to increase their dividends next week, including Hormel, Mastercard, Abbott Laboratories, and AbbVie.
Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive
This year's list is a bit more defensive than in years past and has a focus on earnings growth.
Abbott Laboratories: Another Healthy Dividend Hike From This Dividend King
The most proven dividend growth stocks can be equivalent to a money tree for shareholders. Even as demand for its COVID-19 diagnostic tests continued to fall, Abbott Laboratories outpaced the analy...
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
Finding investment opportunities in tune with today's demographic trends can be challenging, but aging population stocks may be the solution. This market is booming in a world with an aging populat...
Watch These 5 Stocks That Recently Hiked Dividends
Investors may keep a tab on stocks like FULT, SFBS, MOS, ABT and ANDE, which have lately hiked their dividend payments.
PETQ or ABT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or Abbott (ABT). But which of these two companies is the best option for those looking for u...
Here's Why Abbott (ABT) Gained But Lagged the Market Today
Abbott (ABT) reachead $108.42 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.
Abbott (ABT) Gains From Global Expansion Amid Macro Woes
Abbott's (ABT) EPD business continues to witness low double-digit growth. It has successfully positioned itself as one of the best-positioned large healthcare companies in emerging markets.
Abbott (ABT) Advances But Underperforms Market: Key Facts
Abbott (ABT) concluded the recent trading session at $106.68, signifying a +0.43% move from its prior day's close.
2 Healthcare Stocks to Buy Hand Over Fist in December
Abbott Labs has a strong brand name and solid growth avenues despite coronavirus-related issues. Intuitive Surgical's dominance in robotic-assisted surgery is an excellent sign for the company's fu...
Abbott (ABT) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Abbott (ABT) stood at $104.94, denoting a +0.57% change from the preceding trading day.
Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
In 2023, AI and the Magnificent 7 took the lead, leaving non-tech blue chip companies trailing behind in the rearview mirror. Abbott Laboratories had a difficult last three years, with its stock pr...
Abbott (ABT) Rises Higher Than Market: Key Facts
Abbott (ABT) closed the most recent trading day at $104.29, moving +0.64% from the previous trading session.
Related Companies